BMS' Opdivo First EU Approved PD-1 Inhibitor

Sunday, June 21, 2015

Source: PharmaTimes

European regulators have issued a green light for Bristol-Myers Squibb’s Opdivo as a treatment for advanced skin cancer, making it the first PD-1 inhibitor to win approval in the region.

View All News »